Management of Iron-Pill-Induced Gastritis with Ongoing Anemia from Menorrhagia
Switch immediately to intravenous iron therapy and discontinue all oral iron supplementation to allow gastric mucosa healing while effectively treating the underlying iron deficiency anemia. 1
Immediate Management: Discontinue Oral Iron
- Stop all solid oral iron formulations immediately as they cause direct corrosive mucosal damage that can worsen anemia through gastrointestinal bleeding 1, 2
- Iron pill gastritis results from direct contact injury to gastric mucosa, with documented cases showing persistent mucosal irritation when patients continue solid tablets despite recommendations 3
- The gastric erosions and ulcerations will not heal while the causative agent (oral iron pills) continues 4
Optimal Iron Replacement Strategy: Intravenous Iron
Intravenous iron is the preferred treatment approach in this clinical scenario for several compelling reasons:
- IV iron bypasses the gastrointestinal tract entirely, eliminating further gastric mucosal injury while providing effective iron repletion 5
- In patients with severe iron deficiency or conditions where oral iron may not be well absorbed (including gastritis), IV iron should be given initially 5
- Modern IV iron formulations like ferric derisomaltose can deliver up to 1000 mg in a single infusion, providing rapid iron repletion 6
- The 2024 AGA guidelines recognize IV iron as appropriate first-line therapy when oral iron is not tolerated or contraindicated 5
Specific IV Iron Considerations
- Ferric derisomaltose demonstrates superior safety profile with lower incidence of hypophosphatemia (8.4%) compared to older formulations like saccharated ferric oxide (83.2%) 6
- Single high-dose infusions (up to 1000 mg) reduce treatment burden compared to multiple low-dose sessions 6
- The British Society of Gastroenterology recommends ambulatory care settings for IV iron administration 7
Address the Underlying Menorrhagia
While treating iron deficiency, concurrent gynecological evaluation and management of menorrhagia is essential to prevent recurrent iron depletion:
- Ongoing blood loss from menorrhagia will perpetuate the cycle of iron deficiency regardless of replacement therapy 5
- Multidisciplinary management involving gastroenterology and gynecology is recommended for complex cases 5
Gastric Mucosa Healing Monitoring
- Consider repeat endoscopy in 8-12 weeks if symptoms persist after discontinuing oral iron to confirm mucosal healing 1
- Document resolution of gastritis before considering any future oral iron therapy
- Biopsies previously showed iron pill debris and excessive iron deposition, which should resolve with cessation 2
Critical Pitfall to Avoid
The most common error is switching to liquid oral iron formulations when gastritis is present. While liquid iron reduces direct mucosal contact injury compared to pills 3, it still exposes inflamed gastric mucosa to iron and may cause continued irritation. In established iron pill gastritis with documented mucosal injury, IV iron is the safer choice 1.
Long-Term Iron Maintenance
Once iron stores are repleted and gastric mucosa has healed:
- If oral iron is eventually needed, liquid formulations are preferred over solid tablets to minimize recurrence risk 3
- However, given this patient's documented intolerance, periodic IV iron infusions may be the most appropriate long-term strategy, especially if menorrhagia continues 6
- The British Society of Gastroenterology emphasizes that IDA pathways should be delivered by designated teams with senior clinician leadership to optimize management 7